Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Other Non-Current Assets (2022 - 2025)

Historic Other Non-Current Assets for Fennec Pharmaceuticals (FENC) over the last 5 years, with Q3 2025 value amounting to $743000.0.

  • Fennec Pharmaceuticals' Other Non-Current Assets fell 2228.03% to $743000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $743000.0, marking a year-over-year decrease of 2228.03%. This contributed to the annual value of $822000.0 for FY2024, which is 73.53% up from last year.
  • As of Q3 2025, Fennec Pharmaceuticals' Other Non-Current Assets stood at $743000.0, which was down 2228.03% from $768000.0 recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Other Non-Current Assets ranged from a high of $1.0 million in Q1 2024 and a low of $14000.0 during Q2 2022
  • Its 4-year average for Other Non-Current Assets is $548928.6, with a median of $755500.0 in 2025.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first surged by 83301.89% in 2024, then tumbled by 2234.58% in 2025.
  • Fennec Pharmaceuticals' Other Non-Current Assets (Quarter) stood at $211000.0 in 2022, then soared by 286.73% to $816000.0 in 2023, then increased by 0.74% to $822000.0 in 2024, then dropped by 9.61% to $743000.0 in 2025.
  • Its last three reported values are $743000.0 in Q3 2025, $768000.0 for Q2 2025, and $794000.0 during Q1 2025.